Methanex Corporation
NASDAQ:MEOHChemicals
-$1.78 today
- Market cap
- $4.93B
- Beta
- 0.84
- P/E (TTM)
- -92.1
- EPS (TTM)
- -$0.58
- Dividend yield
- 1.39%
Volume 1.24M
Average 1.35M
MEOH Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Methanex CorporationNASDAQ: MEOH
Gross Margin · Q2 FY2026 · quarter ended Jun 2026
Gross margin widens to 45.7%
Gross margin was 45.7% in Q2 FY2026, up 18.7 pp from a year earlier. On a trailing-twelve-month basis it was 28.6%, up 3.8 pp year over year. Over 3 fiscal years it widened by 5.3 pp.
Context
- Gross margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 25.3%
- Year-over-year change
- +6.2pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 25.3% | +6.2pp |
| FY2024 | 2024-12-31 | 19.1% | +1.5pp |
| FY2023 | 2023-12-31 | 17.6% | -2.5pp |
| FY2022 | 2022-12-31 | 20.1% | -4.3pp |
| FY2021 | 2021-12-31 | 24.4% | — |
Gross Margin vs competitors
How MEOH compares with its peers on the latest reported figures
- MEOH's LTM Jun 2026 gross margin of 28.6% is the 2nd highest of the 5 companies compared; the peer median is 12.9%.
- Its year-over-year change of +3.8 pp is the 2nd highest of 5, against a peer median of -1.0 pp.
- Over three fiscal years its change of +5.3 pp compares with a peer median of -8.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 31.4% | -2.7 pp | +6.1 pp | |
| LTM Jun 2026 | 28.6% | +3.8 pp | +5.3 pp | |
| LTM Mar 2026 | 19.6% | +12.0 pp | -21.7 pp | |
| LTM Mar 2026 | 6.1% | -9.4 pp | -16.2 pp | |
| LTM Mar 2026 | 5.8% | +0.7 pp | -1.2 pp | |
| Peer median (excluding MEOH) | 12.9% | -1.0 pp | -8.7 pp | |
Competitors are the stored peer set for MEOH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.41B | 4.31B | 3.72B | 3.72B | 3.59B |
| Cost of Revenue | 3.34B | 3.45B | 3.07B | 3.01B | 2.68B |
| Gross Profit | 1.08B | 865.09M | 655.4M | 710.42M | 909.09M |
| Gross Margin | 24.4% | 20.1% | 17.6% | 19.1% | 25.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 210.85M | 0 | 0 | 0 | 0 |
| Operating Expenses | 363.08M | 372.42M | 391.83M | 385.7M | 446.01M |
| Depreciation & Amortization | 363.08M | 372.42M | 391.83M | 385.7M | 446.01M |
| EBITDA | 1.17B | 1.09B | 794.81M | 798.42M | 868.94M |
| EBITDA Margin | 26.6% | 25.2% | 21.3% | 21.5% | 24.2% |
| Operating Income | 711.97M | 492.67M | 263.57M | 324.72M | 463.08M |
| Operating Margin | 16.1% | 11.4% | 7.1% | 8.7% | 12.9% |
| Interest Income | 1.04M | 25.35M | 39.94M | 12.42M | 25.73M |
| Interest Expense | 144.41M | 131M | 117.37M | 132.63M | 219.69M |
| Other Income / Expenses | (45.63M) | 89.48M | 22.04M | (44.63M) | (259.84M) |
| Income Before Tax | 666.34M | 582.15M | 285.61M | 280.09M | 203.24M |
| Pre-Tax Margin | 15.1% | 13.5% | 7.7% | 7.5% | 5.7% |
| Income Tax Expense | 110.43M | 119.86M | 1.49M | 29.84M | 58.45M |
| Net Income | 482.36M | 353.83M | 174.14M | 163.99M | 79.88M |
| Net Margin | 10.9% | 8.2% | 4.7% | 4.4% | 2.2% |
| EPS (Basic) | 6.34 | 4.95 | 2.57 | 2.43 | 1.10 |
| EPS (Diluted) | 6.13 | 4.86 | 2.57 | 2.39 | 0.93 |
| Weighted Avg Shares | 76.04M | 71.42M | 67.81M | 67.39M | 72.53M |
| Weighted Avg Shares (Diluted) | 76.24M | 71.68M | 67.81M | 67.56M | 72.61M |
Methanex Corporation
NASDAQ:MEOH
Intrinsic Alpha fair value
Locked
Current Price
$63.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.